Cite
HARVARD Citation
Feldmann, M. et al. (2020). Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 395 (10234), pp. 1407-1409. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feldmann, M. et al. (2020). Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 395 (10234), pp. 1407-1409. [Online].